RU2021128158A3 - - Google Patents

Download PDF

Info

Publication number
RU2021128158A3
RU2021128158A3 RU2021128158A RU2021128158A RU2021128158A3 RU 2021128158 A3 RU2021128158 A3 RU 2021128158A3 RU 2021128158 A RU2021128158 A RU 2021128158A RU 2021128158 A RU2021128158 A RU 2021128158A RU 2021128158 A3 RU2021128158 A3 RU 2021128158A3
Authority
RU
Russia
Application number
RU2021128158A
Other languages
Russian (ru)
Other versions
RU2021128158A (ru
Filing date
Publication date
Application filed filed Critical
Publication of RU2021128158A publication Critical patent/RU2021128158A/ru
Publication of RU2021128158A3 publication Critical patent/RU2021128158A3/ru

Links

RU2021128158A 2016-08-09 2017-08-09 Композиции химерного поксвируса и их применение RU2021128158A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662372408P 2016-08-09 2016-08-09
US62/372,408 2016-08-09
US201762519010P 2017-06-13 2017-06-13
US62/519,010 2017-06-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2019106319A Division RU2757002C2 (ru) 2016-08-09 2017-08-09 Композиции химерного поксвируса и их применение

Publications (2)

Publication Number Publication Date
RU2021128158A RU2021128158A (ru) 2022-04-07
RU2021128158A3 true RU2021128158A3 (enExample) 2025-03-18

Family

ID=61163330

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2021128158A RU2021128158A (ru) 2016-08-09 2017-08-09 Композиции химерного поксвируса и их применение
RU2019106319A RU2757002C2 (ru) 2016-08-09 2017-08-09 Композиции химерного поксвируса и их применение

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2019106319A RU2757002C2 (ru) 2016-08-09 2017-08-09 Композиции химерного поксвируса и их применение

Country Status (10)

Country Link
US (2) US12084687B2 (enExample)
EP (1) EP3497209A4 (enExample)
JP (4) JP7023929B2 (enExample)
KR (3) KR20250067190A (enExample)
CN (3) CN118834840A (enExample)
AU (3) AU2017311380A1 (enExample)
CA (1) CA3033512A1 (enExample)
MX (1) MX2019001672A (enExample)
RU (2) RU2021128158A (enExample)
WO (1) WO2018031694A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
EP4122492A1 (en) 2015-02-25 2023-01-25 Memorial Sloan Kettering Cancer Center Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
KR20180006916A (ko) 2015-04-17 2018-01-19 메모리얼 슬로안-케터링 캔서 센터 고형 종양에 대한 면역치료제로서 mva 또는 mva델타e3l의 용도
WO2017147554A2 (en) 2016-02-25 2017-08-31 Memorial Sloan-Kettering Cancer Center Recombinant mva or mvadele3l expressing human flt3l and use thereof as immuno-therapeutic agents against solid tumors
CN109152815B (zh) 2016-02-25 2022-10-18 纪念斯隆凯特琳癌症中心 用于癌症免疫治疗的具有胸苷激酶缺失和具有或不具有人flt3l或gm-csf表达的复制型减毒痘苗病毒
CA3019835A1 (en) 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy
KR20250067190A (ko) * 2016-08-09 2025-05-14 시티 오브 호프 키메라 폭스바이러스 조성물 및 이의 용도
CN110582288B (zh) 2017-02-28 2024-09-20 恩多塞特公司 用于car t细胞疗法的组合物和方法
CN111107872A (zh) 2017-05-12 2020-05-05 纪念斯隆-凯特林癌症中心 有用于癌症免疫疗法的牛痘病毒突变体
CN111163803B (zh) 2017-08-11 2025-05-09 希望之城公司 表达car t细胞靶物的溶瘤病毒及其用途
WO2019144095A1 (en) 2018-01-22 2019-07-25 Seattle Children's Hospital (dba Seattle Children's Research Institute) Methods of use for car t cells
JP7568224B2 (ja) 2018-02-23 2024-10-16 エンドサイト・インコーポレイテッド Car t細胞療法のための配列決定法
CA3093093A1 (en) * 2018-03-07 2019-09-12 Transgene Parapoxvirus vectors
WO2019213173A1 (en) * 2018-04-30 2019-11-07 City Of Hope Neural stem cell compositions including chimeric poxviruses for cancer treatment
CA3112654A1 (en) 2018-09-15 2020-03-19 Memorial Sloan Kettering Cancer Center Recombinant poxviruses for cancer immunotherapy
CN113583977B (zh) * 2020-04-30 2025-06-06 杭州康万达医药科技有限公司 可受微小rna调控的分离的重组溶瘤痘病毒及其应用
GB2614309A (en) 2021-12-24 2023-07-05 Stratosvir Ltd Improved vaccinia virus vectors
WO2023213763A1 (en) * 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
KR20250052416A (ko) 2022-08-18 2025-04-18 트랜스진 키메라 폭스바이러스
WO2024245722A2 (en) * 2023-05-26 2024-12-05 Probiogen Ag Rapid selection system for the generation of recombinant enveloped viruses
US12698512B2 (en) 2023-11-06 2026-08-04 City Of Hope Methods comprising oncolytic viruses expressing CD19T and bispecific T cell engagers
WO2025184411A1 (en) 2024-02-27 2025-09-04 Calidi Biotherapeutics (Nevada), Inc. Serum-resistant eev viruses and uses thereof
WO2026107113A1 (en) 2024-11-12 2026-05-21 Calidi Biotherapeutics (Nevada), Inc. MODIFIED CELLS FOR PROGRAMMING EXTRA ENVELOPED VIRUSES (EEVs) AND THEIR USE FOR PRODUCING THE EEVs, THE PROGRAMMED EEVs AND USES THEREOF
CN120718864B (zh) * 2025-08-28 2025-11-28 山东农业大学 一种高度不成熟鸭坦布苏病毒及其培养方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406376B (de) 1998-01-16 2000-04-25 Immuno Ag Chimäres poxvirus enthaltend eine retrovirale vektorkomponente
JP2003528605A (ja) 2000-03-28 2003-09-30 ユニヴァーシティー オヴ ロチェスター ライブラリーを作成する方法および目的のポリヌクレオチドを選択する方法
ATE365220T1 (de) * 2002-11-25 2007-07-15 Bavarian Nordic As Mindestens zwei ati promotoren enthaltendes rekombinantes pockenvirus
MXPA05013879A (es) * 2003-06-18 2006-06-27 Genelux Corp Virus de la vaccinia recombinantes modificados y otros microorganismos, y usos de los mismos.
EP2415783B1 (en) * 2006-10-16 2016-12-14 Genelux Corporation Modified vaccinia virus strains for use in a diagnostic and therapeutic method
EP2212423B1 (en) * 2007-11-19 2015-02-11 Transgene SA Poxviral oncolytic vectors
JP5652830B2 (ja) 2010-04-09 2015-01-14 国立大学法人 東京大学 マイクロrna制御組換えワクシニアウイルス及びその使用
EP2697368B1 (en) 2011-04-15 2019-06-05 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
NZ701949A (en) * 2012-05-18 2016-07-29 Otago Innovation Ltd Combination treatments and compositions for wound healing
WO2015103438A2 (en) * 2014-01-02 2015-07-09 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
KR20250067190A (ko) * 2016-08-09 2025-05-14 시티 오브 호프 키메라 폭스바이러스 조성물 및 이의 용도

Similar Documents

Publication Publication Date Title
BR102025006099A2 (pt) Método implementado por computador
BR102024017758A2 (pt) Derivado piridil-tiazolidinona jc-21a com atividade fungicida frente candida auris e toxicidade dérmica em ratos
BR102024017432A2 (pt) Dispositivo simulador para treinamento de cuidados médicos
CN308978311S (zh) 壁灯(0027)
CN308974555S (zh) 保温壶(073)
CN308917614S (zh) 陶瓷壶(柴烧玉泉壶)
JP1775646S (enExample)
CN308845931S (zh) 沙发(充气)
CN308768907S (zh) 防潮骨灰盒(福禄双全)
CN308874482S (zh) 手磨咖啡机(上调款2)
CN308416966S (zh) 鞋底(1)
CN308736899S (zh) 茶椅(佳汇)
CN308714043S (zh) 沙发(kab6235g)
CN308609205S (zh) 补衣贴
CN308589890S (zh) 汽车座椅缝隙储物盒
CN308709633S (zh) 包装瓶(健康口袋90epa+dha鱼油凝胶糖果)
CN308734505S (zh) 分体壁挂式空调器(m_q_zz2)
CN308607667S (zh) 旅居客舱(e7)
CN308403154S (zh) 皮草外套(双面穿f-31060)
CN308408432S (zh) 餐桌(Jh04)
CN308407025S (zh) 草坪灯(精灵b款)
CN308407812S (zh) 鞋底(160)
CN308407224S (zh) 吸顶灯(9988)
CN308405665S (zh) 插头(Plug03)
CN308406903S (zh) 数码喷印装饰板(万木春-荣)